Published in Parasite Immunol on April 01, 2003
Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem (2007) 2.44
Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev (2003) 1.59
Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol (2002) 1.44
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study. J Acquir Immune Defic Syndr (2007) 1.43
Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21. Vaccine (2002) 1.16
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. Eur J Immunol (2003) 1.14
Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Biol (2005) 1.08
Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. Microbes Infect (2008) 1.03
Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis. Vaccine (2004) 1.02
Programmed cell death in trypanosomatids: a way to maximize their biological fitness? Trends Parasitol (2004) 1.02
Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Infect Immun (2002) 1.00
Molecular mechanisms for the B-Z transition in the example of poly[d(G-C) x d(G-C)] polymers. A critical review. Chem Rev (2006) 0.98
The translational efficiencies of the two Leishmania infantum HSP70 mRNAs, differing in their 3'-untranslated regions, are affected by shifts in the temperature of growth through different mechanisms. J Biol Chem (2005) 0.97
Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice. Infect Immun (2005) 0.97
Characterization of the immune response to Leishmania infantum recombinant antigens. Microbes Infect (2003) 0.97
The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones (2002) 0.96
Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives. Curr Med Chem (2008) 0.94
Analysis of a delayed epidemic model with pulse vaccination and saturation incidence. Vaccine (2006) 0.94
Identification of an hepatitis delta virus-like ribozyme at the mRNA 5'-end of the L1Tc retrotransposon from Trypanosoma cruzi. Nucleic Acids Res (2011) 0.93
Molecular modeling and in silico characterization of Mycobacterium tuberculosis TlyA: possible misannotation of this tubercle bacilli-hemolysin. BMC Struct Biol (2011) 0.92
Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules. J Biol Chem (2010) 0.92
Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion. Protein Sci (2005) 0.92
Thermodynamic stability of the C-terminal domain of the human inducible heat shock protein 70. Biochim Biophys Acta (2004) 0.92
Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine (2009) 0.91
Computational prediction and experimental assessment of secreted/surface proteins from Mycobacterium tuberculosis H37Rv. PLoS Comput Biol (2010) 0.91
The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice. Infect Immun (2003) 0.91
Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Ann Epidemiol (2011) 0.90
Images in clinical medicine. Digital mucous cyst. N Engl J Med (2012) 0.90
Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells. Med Chem (2006) 0.90
The expression of HSP83 genes in Leishmania infantum is affected by temperature and by stage-differentiation and is regulated at the levels of mRNA stability and translation. BMC Mol Biol (2004) 0.89
H-ras and N-ras are dispensable for T-cell development and activation but critical for protective Th1 immunity. Blood (2011) 0.89
Gender-based violence and mental disorders in female college students. Soc Psychiatry Psychiatr Epidemiol (2012) 0.89
Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration. Pharm Res (2004) 0.89
Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy. Recent Pat Anticancer Drug Discov (2006) 0.89
Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein. J Biol Chem (2006) 0.88
Recent advances in vaccines for leishmaniasis. Expert Opin Biol Ther (2004) 0.88
Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells. Vaccine (2008) 0.88
Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies. Glycoconj J (2007) 0.88
Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides. Protein Sci (2005) 0.88
Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes. Biochem Biophys Res Commun (2005) 0.87
Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells. J Biol Chem (2005) 0.87
Inhibition of Bacillus subtilis natural competence by a native, conjugative plasmid-encoded comK repressor protein. Environ Microbiol (2012) 0.87
[Effectiveness of a multifactorial strategy for implementing clinical guidelines on unstable angina: cluster randomized trial]. Rev Esp Cardiol (2005) 0.87
Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts. Clin Vaccine Immunol (2009) 0.86
Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments. Vaccine (2003) 0.86
Reference strand conformational analysis (RSCA) is a valuable tool in identifying MHC-DRB sequences in three species of Aotus monkeys. Immunogenetics (2006) 0.86
Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2. Biochem Biophys Res Commun (2005) 0.86
Pharmacological modulation of Poly(ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapy. Mol Pharmacol (2003) 0.86
Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)]. Mol Pharmacol (2003) 0.85
The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection. Vaccine (2006) 0.85
Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants. Clin Diagn Lab Immunol (2002) 0.85
Conserved nucleotides surrounding the trans-splicing acceptor site and the translation initiation codon in Leishmania genes. Exp Parasitol (2003) 0.85
Cell-cycle-dependent translation of histone mRNAs is the key control point for regulation of histone biosynthesis in Leishmania infantum. Biochem J (2004) 0.85
Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. Vaccine (2004) 0.85
Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge. Microbes Infect (2010) 0.85
Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics (2009) 0.84
Comparison of relaxation training with a cognitive-behavioural intervention for indicated prevention of depression in university students: a randomized controlled trial. J Psychiatr Res (2012) 0.84
Antigenic properties of the Leishmania infantum GRP94 and mapping of linear B-cell epitopes. Immunol Lett (2002) 0.84
The diagnostic performance of classical molecular tests used for detecting human papillomavirus. J Virol Methods (2012) 0.84
Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice. Microbes Infect (2007) 0.84
Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages. Immunogenetics (2006) 0.84
The biology and evolution of transposable elements in parasites. Trends Parasitol (2010) 0.84
A novel antifungal peptide designed from the primary structure of a natural antimicrobial peptide purified from Argopecten purpuratus hemocytes. Peptides (2009) 0.84
MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochem Biophys Res Commun (2004) 0.84
Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women. J Clin Microbiol (2013) 0.84
Identifying gp85-regions involved in Epstein-Barr virus binding to B-lymphocytes. Biochem Biophys Res Commun (2004) 0.84
Schwann cell-enriched cultures from adult human peripheral nerve: a technique combining short enzymatic dissociation and treatment with cytosine arabinoside (Ara-C). J Neurosci Methods (2002) 0.83
Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC. Vaccine (2007) 0.83
Identification of the Plasmodium falciparum rhoptry neck protein 5 (PfRON5). Gene (2010) 0.83
Novel transplatinum(II) complexes with [N2O2] donor sets. Cellular pharmacology and apoptosis induction in Pam 212-ras cells. J Med Chem (2006) 0.83
Identification and polymorphism of Plasmodium vivax RBP-1 peptides which bind specifically to reticulocytes. Peptides (2002) 0.83
Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells. Peptides (2005) 0.83
Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen. BMC Microbiol (2010) 0.83
Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes. Protein Sci (2005) 0.83
Introns form compositional clusters in parallel with the compositional clusters of the coding sequences to which they pertain. J Mol Evol (2010) 0.82
Cutaneous tuberculosis diagnosis in an inhospitable Amazonian region by means of telemedicine and molecular biology. J Am Acad Dermatol (2005) 0.82
Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate. Eur J Pharm Sci (2011) 0.82
Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP). Vaccine (2003) 0.81
Allele effects in MHC-peptide interactions: a theoretical analysis of HLA-DRbeta1*0101-HA and HLA-DRbeta1*0401-HA complexes. Biochem Biophys Res Commun (2005) 0.81
Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin. Chem Biodivers (2005) 0.81
A new approach to obtaining Nα -t-Boc-amino acid aldehydes from asparagine and glutamine for reduced amide pseudopeptide solid-phase synthesis. Chem Biol Drug Des (2011) 0.81
Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples. PLoS One (2013) 0.81
Protection against experimental malaria associated with AMA-1 peptide analogue structures. FEBS Lett (2002) 0.81
Midpoints for fuzzy sets and their application in medicine. Artif Intell Med (2003) 0.81
NClassG+: A classifier for non-classically secreted Gram-positive bacterial proteins. BMC Bioinformatics (2011) 0.81
Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis. Parasit Vectors (2014) 0.81
Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design. Clin Microbiol Rev (2006) 0.81
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge. J Biomed Biotechnol (2010) 0.81
Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines. Vaccine (2008) 0.81
Monocyte-derived dendritic cells from chagasic patients vs healthy donors secrete differential levels of IL-10 and IL-12 when stimulated with a protein fragment of Trypanosoma cruzi heat-shock protein-70. Immunol Cell Biol (2008) 0.81
Nucleic-acid-binding properties of the C2-L1Tc nucleic acid chaperone encoded by L1Tc retrotransposon. Biochem J (2009) 0.80
A modified protocol for RNA isolation from high polysaccharide containing Cupressus arizonica pollen. Applications for RT-PCR and phage display library construction. Mol Biotechnol (2010) 0.80
Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes. Peptides (2003) 0.80
A theoretical analysis of HLA-DRbeta1*0301-CLIP complex using the first three multipolar moments of the electrostatic field. Biochimie (2006) 0.80
Determining the 3D structure of human ASC2 protein involved in apoptosis and inflammation. Biochem Biophys Res Commun (2005) 0.80